3 completed, 1 terminated, 1 unknown, 1 withdrawn. 1 Phase 1, 1 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow rhIL-11: new trials by email Literature Review of rhIL-11 trials Research Report on rhIL-11
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Evaluate Thrombosis Risk in Chemotherapy Patients With Solid Tumors Who Receiving Thrombocytopenia Treatment Recombinant Human Interleukin-11 for Injection - Chemotherapy-induced Thrombocytopenia | Completed | Liaoning Cancer Hospital & Institute | 3494 | 2020-09-02 | 2023-01-18 | |
| Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With Thrombocytopenia rhTPO, irinotecan, Raltitrexed - Recurrent Colorectal Carcinoma, Thrombopenia | Phase 2 | Unknown | Fudan University | 50 | 2019-02-01 | 2019-01-30 |
| A Phase Ⅲa Study of Genetically Modified Recombinant Human Interleukin-11 NL201, rhIL-11 - Chemotherapy-induced Thrombocytopenia | Phase 3 | Completed | Beijing Northland Biotech. Co., Ltd. | 62 | 2015-03-01 | 2020-09-16 |
| Effect of rhIL-11 in Patients With Thrombocytopenia for Childhood ALL rhIL-11 - Pancytopenia Due to Chemotherapy | Phase 4 | Completed | Shanghai Children's Medical Center | 120 | 2011-09-01 | 2014-12-11 |
| Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune Thrombocytopenia rhIL-11 - Purpura, Thrombocytopenic, Idiopathic | Withdrawn | Ming Hou | 2011-03-01 | 2016-04-20 | ||
| Study Evaluating rhIL-11 in Left-Sided Ulcerative Colitis rhIL-11 - Ulcerative Colitis, Inflammatory Bowel Disease | Phase 1 | Terminated | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-05-18 |
Thrombocytopenia (2) · Colitis (1) · Colitis, Ulcerative (1) · Colorectal Neoplasms (1) · Inflammatory Bowel Diseases (1) · Purpura, Thrombocytopenic, Idiopathic (1) · Ulcer (1)
Beijing Northland Biotech. Co., Ltd. (1) · Fudan University (1) · Liaoning Cancer Hospital & Institute (1) · Ming Hou (1) · Shanghai Children's Medical Center (1) · Wyeth is now a wholly owned subsidiary of Pfizer (1)
China (4)
Ming Hou, Dr. (1) · Tang Jingyan, M.D. (1) · Xiaojing Xing (1) · Zhen Zhang, MD (1)